Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001437749-22-027849)

Filing Details

Accession Number:: 0001437749-22-027849
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-11-21 16:15:22
Reporting Period:: 2022-11-18

Accepted Time:: 2022-11-21 16:15:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1742927	Reviva Pharmaceuticals Holdings Inc.	RVPH	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1818246	Purav Patel	C/O Reviva Pharmaceuticals Holdings, Inc 19925 Stevens Creek Blvd, Suite 100 Cupertino CA 95014		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	Acquisiton	2022-11-18	3,000	$4.69	43,547	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	28,742	Indirect	By Segura Fund LLC
Common Stock, Par Value $0.0001 Per Share	3,318	Indirect	By Buena Vista Fund II, LLC

Footnotes

The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.